| Product Name | MF | CAS | Details |
|---|
| Anti-GDF8 / Myostatin Reference Antibody (domagrozumab) | Details |
| Anti-GDF8 / Myostatin Reference Antibody (landogrozumab) | Details |
| Anti-GDF8 / Myostatin Reference Antibody (trevogrumab) | Details |
| Anti-GFRA3 Reference Antibody (nadecnemab) | Details |
| Anti-GFRAL Reference Antibody (NGM120) | Details |
| Anti-GIPR Reference Antibody (Amgen patent anti-GIPR) | Details |
| Anti-GLP1R Reference Antibody (Centocor patent anti-GLP-1R) | Details |
| Anti-GM3 Reference Antibody (racotumomab) | Details |
| Anti-GOLM1 Reference Antibody (Cureab patent anti-GP73) | Details |
| Anti-GP6 / Glycoprotein-6 Reference Antibody (glenzocimab) | Details |
| Anti-GPA33 Reference Antibody (KRN330) | Details |
| Anti-GPC1 / Glypican-1 Reference Antibody (Minomic patent anti-Glypican 1) | Details |
| Anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab) | Details |
| Anti-GPNMB Reference Antibody (glembatumumab) | Details |
| Anti-GPR20 Reference Antibody (DS-6157) | Details |
| Anti-GPR44 / PTGDR2 / CD294 Reference Antibody (KHK patent anti-CRTH2) | Details |
| Anti-GPR49 / LGR5 Reference Antibody (BNC101) | Details |
| Anti-GPR49 / LGR5 Reference Antibody (petosemtamab) | Details |
| Anti-GPR64 / ADGRG2 Reference Antibody (Facet patent anti-GPR64) | Details |
| Anti-GPR73 / PROKR1 Reference Antibody (Regeneron patent anti-PROKR1) | Details |
| Anti-GPRC5D Reference Antibody (talquetamab) | Details |
| Anti-GREM1 / Gremlin Reference Antibody (Regeneron patent anti-GREM1) | Details |
| Anti-GREM1 / Gremlin Reference Antibody (UCB patent anti-Gremlin-1) | Details |
| Anti-GUCY2C Reference Antibody (indusatumab) | Details |
| Anti-H3L Antibody (NAL_A185) | Details |
| Anti-Haptoglobin Reference Antibody (KHK patent anti-Haptoglobin) | Details |
| Anti-HBEGF Reference Antibody (KHK2866) | Details |
| Anti-HBEGF Reference Antibody (U3-1565) | Details |
| Anti-Hepcidin / HAMP Reference Antibody (Ludwig-Maximilians U. anti_Hepsin) | Details |
| Anti-Hepcidin / HAMP Reference Antibody (LY2787106) | Details |
| Anti-HGF / SF Reference Antibody (ficlatuzumab) | Details |
| Anti-HGF / SF Reference Antibody (rilotumumab) | Details |
| Anti-HGF / SF Reference Antibody (TAK-701) | Details |
| Anti-HGFA Reference Antibody (Genentech patent anti-HGFA ) | Details |
| Anti-HGFR / c-Met Reference Antibody (amivantamab) | Details |
| Anti-HGFR / c-Met Reference Antibody (emibetuzumab) | Details |
| Anti-HGFR / c-Met Reference Antibody (Korea RIBB patent anti-cMet) | Details |
| Anti-HGFR / c-Met Reference Antibody (Metheresis patent anti-Met) | Details |
| Anti-HGFR / c-Met Reference Antibody (onartuzumab) | Details |
| Anti-HGFR / c-Met Reference Antibody (SAIT301) | Details |
| Anti-HGFR / c-Met Reference Antibody (telisotuzumab) | Details |
| Anti-Histone H1 Reference Antibody (derlotuximab) | Details |
| Anti-Histone H2B Reference Antibody (Immunomedics patent anti-Histone H2B) | Details |
| Anti-Histone H3 Reference Antibody (Immunomedics patent anti-Histone H3) | Details |
| Anti-Histone H4 Reference Antibody (Immunomedics patent anti-Histone H4) | Details |
| Anti-FZD10 Reference Antibody (tabituximab) | Details |
| Anti-FZD7 Reference Antibody (U.Toronto patent anti-FZD7) | Details |
| Anti-GAD65 Reference Antibody (U.Washington patent anti-GAD65) | Details |
| Anti-GCGR Reference Antibody (crotedumab) | Details |
| Anti-GCGR Reference Antibody (volagidemab) | Details |
| Anti-GD2 Reference Antibody (dinutuximab) | Details |
| Anti-GD2 Reference Antibody (EMD 273063) | Details |
| Anti-GD2 Reference Antibody (naxitamab) | Details |
| Anti-GD3 Reference Antibody (ecromeximab) | Details |
| Anti-GDF15 / MIC-1 Reference Antibody (ponsegromab) | Details |
| Anti-GDF8 / Myostatin Reference Antibody (apitegromab) | Details |
| Anti-HLA-DR Reference Antibody (IMMU-114) | Details |
| Anti-HTRA1 Reference Antibody (FHTR2163) | Details |
| Anti-ICAM1 / CD54 Reference Antibody (bersanlimab) | Details |
| Anti-ICAM3 / CD50 Reference Antibody (Forerunner patent anti-ICAM-3) | Details |
| Anti-ICOS / CD278 Reference Antibody (alomfilimab) | Details |
| Anti-ICOS / CD278 Reference Antibody (feladilimab) | Details |
| Anti-ICOS / CD278 Reference Antibody (MEDI-570) | Details |
| Anti-ICOS / CD278 Reference Antibody (vopratelimab) | Details |
| Anti-IDO2 Reference Antibody (LIMR patent anti-IDO2) | Details |
| Anti-IFNa1 Reference Antibody (Baylor patent anti-IFN alpha) | Details |
| Anti-IFNa1 Reference Antibody (Chinese CDC patent anti-Interferon Alpha) | Details |
| Anti-IFNa1 Reference Antibody (rontalizumab) | Details |
| Anti-IFNa1 Reference Antibody (sifalimumab) | Details |
| Anti-IFNAR1 Reference Antibody (anifrolumab) | Details |
| Anti-IFNAR1 Reference Antibody (Medarex patent anti-IFNAR-1) | Details |
| Anti-IFNg Reference Antibody (AMG 811) | Details |
| Anti-IFNg Reference Antibody (emapalumab) | Details |
| Anti-IFNg Reference Antibody (fontolizumab) | Details |
| Anti-IgE (M1 prime) Reference Antibody (quilizumab) | Details |
| Anti-IgE Reference Antibody (ligelizumab) | Details |
| Anti-IgE Reference Antibody (omalizumab) | Details |
| Anti-IgE Reference Antibody (talizumab) | Details |
| Anti-IGF1 Reference Antibody (xentuzumab) | Details |
| Anti-IGF1R / CD221 Reference Antibody (cixutumumab) | Details |
| Anti-IGF1R / CD221 Reference Antibody (dalotuzumab) | Details |
| Anti-IGF1R / CD221 Reference Antibody (figitumumab) | Details |
| Anti-IGF1R / CD221 Reference Antibody (ganitumab) | Details |
| Anti-IGF1R / CD221 Reference Antibody (Immunomedics patent anti-IGF-1R) | Details |
| Anti-IGF1R / CD221 Reference Antibody (lonigutamAb) | Details |
| Anti-IGF1R / CD221 Reference Antibody (robatumumab) | Details |
| Anti-IGF1R / CD221 Reference Antibody (teprotumumab) | Details |
| Anti-IGF2 Reference Antibody (DX-2647) | Details |
| Anti-IL-10 Reference Antibody (BT-063) | Details |
| Anti-IL-12 (IL-12a & IL-12b) Reference Antibody (briakinumab) | Details |
| Anti-IL-12b Reference Antibody (ebdarokimab) | Details |
| Anti-IL-13 Reference Antibody (abrezekimab) | Details |
| Anti-IL-13 Reference Antibody (anrukinzumab) | Details |
| Anti-IL-13 Reference Antibody (cendakimab) | Details |
| Anti-IL-13 Reference Antibody (CNTO 607) | Details |
| Anti-IL-13 Reference Antibody (dectrekumab) | Details |
| Anti-IL-13 Reference Antibody (GSK 679586) | Details |
| Anti-IL-13 Reference Antibody (H2L6) | Details |
| Anti-IL-13 Reference Antibody (IMA-026) | Details |
| Anti-IL-13 Reference Antibody (lebrikizumab) | Details |
| Product Total： Product Page： | ||||
| 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 | ||||